It has been reported in the literature that tumor cells with CD44-high & CD133-high exhibit stronger tumor stem properties than those with CD44-low & CD133-high or CD44-high & CD133-low, such as higher tumorigenicity, stronger self-renewal ability, stronger drug resistance, and more stem related genes (6). This evidence concerns the gene CD44 and neoplasm.